Header Logo

Connection

Mark Pollack to Citalopram

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Citalopram.
Mark Pollack
Connection Strength
0.870
Citalopram
  1. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
    View in: PubMed
    Score: 0.314
  2. Citalopram for social phobia: a clinical case series. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct; 25(7):1469-74.
    View in: PubMed
    Score: 0.199
  3. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56.
    View in: PubMed
    Score: 0.112
  4. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry. 2009 Nov; 70(11):1563-70.
    View in: PubMed
    Score: 0.087
  5. Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8.
    View in: PubMed
    Score: 0.082
  6. Complicated grief: a case series using escitalopram. Am J Psychiatry. 2007 Nov; 164(11):1760-1.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.